Sai Life, Divi's Labs Emerge As Jefferies' Top Picks In CRDMO; Piramal Pharma, Cohance See Target Price Cut
Published on: Jan. 9, 2026, 8:19 a.m. | Source: NDTV Profit
The pharma pack will be in focus heading into trade on Friday after Jefferies' latest note that witnessed target price hikes for key stocks such as DIvi's Laboratories, Sai Life Science while Piramal Pharma, Cohance saw their price targets cut. In its latest note, the brokerage firm has come out with a note on companies that are involved in contract research, development, and manufacturing organisation (CRDMO) space.
